Next Article in Journal
Lotus Bee Pollen Extract Inhibits Isoproterenol-Induced Hypertrophy via JAK2/STAT3 Signaling Pathway in Rat H9c2 Cells
Previous Article in Journal
Coping with Oxidative Stress in Reproductive Pathophysiology and Assisted Reproduction: Melatonin as an Emerging Therapeutical Tool
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 12
Issue 1
10.3390/antiox12010087
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Antioxidant Auraptene Improves Aged Oocyte Quality and Embryo Development in Mice

by
Yun-Hee Kim
1,
Su-Yeon Lee
1,
Eun-Young Kim
1,
Kyeoung-Hwa Kim
1,
Mi-Kyoung Koong
2 and
Kyung-Ah Lee
1,*
1
Department of Biomedical Science, Institute of Reproductive Medicine, College of Life Science, CHA University, Pangyo-ro 335, Bundang-gu, Seongnam-si 13488, Republic of Korea
2
CHA Fertility Center Daegu Station, Dalgubeol-daero 2095, Jung-gu, Daegu 41936, Republic of Korea
*
Author to whom correspondence should be addressed.
Antioxidants 2023, 12(1), 87; https://doi.org/10.3390/antiox12010087
Submission received: 22 November 2022 / Revised: 16 December 2022 / Accepted: 28 December 2022 / Published: 30 December 2022
Browse Figures
Versions Notes

Abstract

:
Decrease in quality of postovulatory aged oocytes occurs due to oxidative stress and leads to low fertilization and development competence. It is one of the main causes that exerting detrimental effect on the success rate in assisted reproductive technology (ART). Auraptene (AUR), a citrus coumarin, has been reported to possess an antioxidant effects in other tissues. In this study, we aimed to confirm the potential of AUR to delay the oocyte aging process by alleviating oxidative stress. Superovulated mouse oocytes in metaphase of second meiosis (MII) were exposed to 0, 1 or 10 μM AUR for 12 h of in vitro aging. AUR addition to the culture medium recovered abnormal spindle and chromosome morphology and mitigated mitochondrial distribution and mitochondrial membrane potential (ΔΨ) in aged oocytes. AUR-treated aged oocytes also showed suppressed oxidative stress, with lower reactive oxygen species (ROS) levels, higher glutathione (GSH) levels and increased expression of several genes involved in antioxidation. Furthermore, AUR significantly elevated the fertilization and embryo developmental rates. Oocytes aged with 1 μM AUR exhibited morphokinetics that were very similar to those of the control group. Altogether, these data allowed us to conclude that AUR improved the quality of aged oocytes and suggest AUR as an effective clinical supplement candidate to prevent postovulatory aging.

1. Introduction

Auraptene (7-geranyloxycoumarin, AUR) is a natural bioactive coumarin derivative that can be isolated from citrus fruits [1]. In a recent study, it has been shown that AUR has a variety of pharmacological actions, including antioxidative, anti-inflammatory, anticancer, neuroprotective, and immunomodulatory properties [2,3,4,5,6]. Additionally, there was no significant difference in acute and subacute toxic histopathological effects and immunotoxicity evaluation in rats [7]. With respect to controlled randomized trials, there has been no report of side effects on AUR administration in healthy adults [8] or older persons [9]. Therefore, it has been suggested to be a potential therapeutic substance in the prevention and treatment of various diseases [1]. Despite AUR’s broad range of biological activities, there is a lack of research addressing the effect of AUR in in vitro oocyte aging and embryo development.
After ovulation, female oocytes arrested at the metaphase of the second meiosis (MII) and await fertilization by spermatozoa either in the oviduct or in culture media in vitro. If fertilization does not occur over a prolonged period, oocytes progressively undergo a time-dependent deterioration in quality, which is referred to as postovulatory aging [10]. Not surprisingly, there are various oocyte defects that postovulatory aged oocytes exhibit, including spindle abnormalities, the loss of chromosomal integrity, mitochondrial dysfunction, calcium oscillation, partial cortical granule exocytosis and zona hardening [11,12,13,14]; thus, these cellular and molecular changes ultimately have damaging consequences for fertilization and subsequent embryonic development.
The mechanisms controlling postovulatory aging have not been well defined; however, there is accumulating evidence indicating that oxidative stress is strongly associated with a decline in postovulatory aged oocyte quality [15]. The aging process is accompanied by the overproduction of ROS. The shift in the balance between the production of ROS and antioxidant enzymes is disrupted, which, in turn causes oxidative stress [16]. In particular, postovulatory aging is inevitable for oocytes with increasing culture time following ovulation during assisted reproductive technologies (ARTs) which are widely used to treat infertility [17]. In addition, in vitro ART procedures contribute to the generation of oxidative stress through the technique itself and its performance in the absence of an endogenous defense system [18]. This oxidative damage may occasionally accelerate the onset of apoptosis in oocytes and ultimately influence their capacity for fertilization and embryo development. Thus, supplementation with antioxidants can be used as a safe and effective strategy to delay or prevent oocyte aging by alleviating oxidative stress.
It is essential to understand the molecular mechanism underlying how oxidative stress is relieved and antioxidant capacity is enhanced in oocyte aging. Nuclear factor erythroid-2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidants that protect against oxidative damage. NRF2 is maintained in the cytoplasm at a low level while undergoing constant proteasomal degradation by a negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), under homeostatic conditions. In response to stress, NRF2 dissociates from KEAP1, allowing it to translocate into the nucleus and bind to DNA promoters and antioxidant response elements (AREs) [19]. Stress-inducible activation of NRF2 leads to the transcription of antioxidative genes, including NAD(P)H:quinone-oxidoreductase-1 (Nqo1), glutamate-cysteine ligase (Gcl), glutathione S-transferase (Gst) and glutathione peroxidase (Gpx). The age-dependent change in the oxidative stress response thus involves the NRF2/KEAP1 signaling system [20].
This study aimed to explore whether AUR can protect oocytes against oxidative stress during postovulatory aging and elucidate the underlying cellular and molecular mechanisms of these effects. Taken together, these data allowed us to propose the use of AUR as a candidate antioxidant culture medium supplement to improve success rates in ART programs.

2. Materials and Methods

2.1. Oocyte Collection and Culture

All animals provided by Koatech (Pyeongtack, Gyeonggi, Republic of Korea) were maintained under standard temperature and humidity conditions with a 12 h light-dark cycle at the Laboratory Animal Research Center of CHA University. Female 3-week-old ICR mice were mainly used in this study, and BDF1 mice were used for only IVF and a time-lapse imaging system. To collect MII oocytes, superovulation was induced by intraperitoneal injections of 10 IU of human chorionic gonadotropin (hCG, Sigma–Aldrich, St. Louis, MO, USA) 48 h after intraperitoneal injections of 5 IU of pregnant mares serum gonadotropin (PMSG, Daesung, Uiwang, Gyeonggi, Republic of Korea). After 16 h, the female mice were sacrificed to collect the cumulus-oocyte complex (COC) from the oviduct ampullar. To obtain cumulus-free oocytes, cumulus cells (CC) were removed by pipetting with hyaluronidase (Sigma–Aldrich). For the Young control group, oocytes were used for the experiment as soon as the cumulus cells were removed. For the aged group, denuded oocytes were washed at least three times, immediately placed in M16 medium (Sigma–Aldrich) containing 1% penicillin–streptomycin (Gibco, Grand Island, NY, USA) and cultured for 12 h at 37 °C in an atmosphere of 5% CO2. For the POA+AUR groups, AUR purchased from Sigma–Aldrich was dissolved in dimethyl sulfoxide (DMSO, Sigma–Aldrich) and diluted to a final concentration of 1 or 10 μM in M16 medium where the DMSO concentration did not exceed 0.01% [21]. Oocytes were cultured in M16 supplemented with different concentrations of AUR (1 or 10 μM) for 12 h at 37 °C in an atmosphere of 5% CO2.

2.2. Immunofluorescence Staining

MII oocytes were washed in phosphate-buffered saline (PBS) containing 0.1% polyvinyl alcohol (PVA), fixed in 4% paraformaldehyde (PFA) and then permeabilized with 0.2% Triton X-100 for 20 min. After 1 h of blocking in 3% bovine serum albumin (BSA) dissolved in PVA-PBS, the samples were incubated overnight at 4 °C with the primary antibody (anti-α-tubulin antibody, Santa Cruz Biotechnology, Dallas, TX, USA, 1:100). After three washes with 0.1% PVA-PBS, oocytes were labeled with secondary antibody (Alexa Fluor 488 goat anti-mouse IgG, Invitrogen, Carlsbad, CA, USA, 1:100) at room temperature (RT) for 1 h and then counterstained with 500 μM DAPI (Sigma–Aldrich) for chromosome staining. After washing with 0.1% PVA-PBS, the oocytes were mounted with a cover glass, and the fluorescence signal was measured by a confocal microscope (Leica TCS SP5 II, Leica, Wetzlar, Germany) with the same parameters.

2.3. JC-1 Assay for Mitochondrial Activity

To evaluate the change in ΔΨm in the oocytes, oocytes were stained with eBioscience™ JC-1 Mitochondria Membrane Potential Dye (Thermo Fisher Scientific, Waltham, MA, USA). Oocytes were cultured in M16 medium supplemented with JC-1 (1 μg/mL) for 30 min at 37 °C in 5% CO2 and then washed with PVA-PBS. The oocytes were mounted with mineral oil, and signals in the red and green fluorescence channels were immediately captured under a confocal microscope. For quantitative analysis, LAS AF Lite software (version 2.3.5 build 5379) was used to measure the signal intensities, and ΔΨm was calculated as the ratio of the red and green signals. In the case of a higher ΔΨm, the ratio was shifted more toward red fluorescence, and the color of the emitted fluorescence changed from green to red. Conversely, with a lower ΔΨm, the ratio decreased and green fluorescence was exhibited. Therefore, healthy mitochondria show a higher red to green fluorescence intensity ratio in a state with a high ΔΨm.

2.4. Measurement of Intracellular ROS and Glutathione (GSH) Levels

An OxiSelect™ Intracellular ROS Assay kit (STA-342, Cell Biolabs, San Diego, CA, USA) and CellTracker™ Blue CMF2HC dye (C12881, Invitrogen) were used to measure the intracellular ROS and GSH levels in denuded oocytes. In brief, oocytes were incubated in M16 medium supplemented with 1X 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) for 30 min at 37 °C or 0.1% PVA-PBS containing 1 μg/mL CMF2HC in the dark at RT. After washing, the fluorescence signal was measured by a confocal microscope with the same parameters. The intensity of the ROS and GSH signals in each oocyte from different groups was measured with ImageJ software (NIMH, Bethesda, MD, USA).

2.5. Real-Time RT-PCR

To detect NRF2 signaling-related transcript expression, mRNA was isolated from 20 MII oocytes in group using the Dynabeads mRNA DIRECT kit (Invitrogen) as described in a previous report [22]. Magnetic beads covalently bound to oligo-dT primer were specifically targeted and captured by base pairing poly(A) tail residues at the mRNA 3′ end. After washing with buffers, RNA was eluted and reverse-transcribed into complementary DNA (cDNA) using M-MLV-RT (Promega, Madison, WI, USA) with oligo(dT) primer. The synthesized cDNA was stored at −20 °C until use. The sequences of the gene-specific primers used for real-time RT–PCR are listed in Table 1. The expression of the transcripts was quantified using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) with a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Relative gene expression levels were calculated using the 2−∆∆Ct method and analyzed.

2.6. Western Blot

Lysates from 300 mouse oocytes per sample were prepared in RIPA buffer containing 100X phosphatase inhibitor. The samples were boiled for 5 min at 95 °C and loaded onto 8% SDS–PAGE, and the protein was separated using electrophoresis and transferred from the gel to PVDF membranes. The membranes were blocked and incubated with anti-NRF2 antibody (ab92946, Abcam, Cambridge, UK) and anti-α-tubulin antibody (sc-8035, Santa Cruz Biotechnology, Dallas, TX, USA) diluted 1:1000 in blocking solution at 4 °C overnight. Next, HRP-conjugated anti-rabbit secondary antibody or HRP-conjugated anti-mouse secondary antibody diluted 1:5000 in blocking solution was added for 1 h of incubation at RT. After washing with TBST, an enhanced chemiluminescence kit was used to detect the specific proteins. The bands were visualized using the ChemiDoc XRS+ system (Bio-Rad). The relative intensity of each band was analyzed using Image Lab software (version 6.1.0 build 7, Standard Edition, Bio-Rad).

2.7. In Vitro Fertilization

The cauda epididymis of 8- to 12-week-old BDF-1 male mice was slightly incised, and sperm were squeezed out using a needle. Sperm were placed into a dish of human tubal fluid (HTF, Sigma–Aldrich) medium covered with mineral oil and then incubated for 1 h at 37 °C in 5% CO2 to allow the sperm to capacitate. At the end of 12 h aging time of POA groups, young oocytes were collected and the CC removed, and the Young group was performed IVF simultaneously with the POA oocyte group. MII oocytes of all groups were added to the HTF droplets at a concentration of 4 × 105 sperm per 1 mL for 6 h at 37 °C in 5% CO2. To remove the sperm, the oocytes were repeatedly and thoroughly washed and transferred to plain M16 medium containing 0.1 mM EDTA that had been equilibrated overnight in the incubator for 120 h of culture.

2.8. Time-Lapse Imaging System

A time-lapse imaging system was used to track phenotypic changes and the speed of embryo development during in vitro culture. Embryos were cultured under a time-lapse microscope (iEM900, CNC Biotech, Seoul, Republic of Korea), and their developmental events were examined and evaluated. A culture dish containing two pronuclei (2PN) zygotes was placed in the microscope. Images were automatically captured every 5 min for 120 h, and the sequential time-lapse images were converted into movie files. The morphokinetics of the embryos were recorded according to the timing at which specific events occurred: t0, time to insemination; tf, pronuclei fading and the entry into the first embryonic M-phase; t2, t3, t4, t5, t6, t7, and t8: time in hours post insemination (HPI) required for the embryos to reach the 2-, 3-, 4-, 5-, 6-, 7-, and 8-cell stage, respectively; tErB, time to start formation of the blastocoel cavity; tBL: half or more of the blastocoel cavity formed; CC, length of cell cycle; and S, synchronicity or the round of cleavage division.

2.9. Statistical Analysis

Statistical analysis was performed using IBM SPSS Statistics 22.0 software (IBM Corp., Armonk, NY, USA). Data are presented as the mean ± standard error of the mean (SEM). The mean and SEM of the data were calculated and statistically analyzed by analysis of variance (ANOVA) followed by post hoc analysis and Student’s t test. Differences were considered biologically significant at p values < 0.05.

3. Results

3.1. AUR Maintains Spindle Assembly and Chromosome Alignment during Postovulatory Aging

To investigate whether AUR has beneficial effects on aging oocytes, oocytes were additionally cultured in vitro for 12 h to induce postovulatory aging in the presence of 0, 1, or 10 μM AUR in the culture medium (Figure 1a). We examined spindle organization and chromosome alignment in aged oocytes. As shown in Figure 1b, young control MII oocytes displayed a barrel-shaped spindle with chromosomes that were well aligned at the equatorial plate. In contrast, in aged oocytes without AUR treatment, the number of elongated spindles or disrupted spindles with misaligned chromosomes was markedly increased compared to that in young oocytes (spindle length: Figure 1c; abnormal rate: Figure 1d). However, the AUR-treated aged oocytes showed a significantly reduced number of abnormal spindles compared to the nontreated aged oocytes. The above results showed that AUR can suppress abnormalities in spindle organization and chromosome alignment in in vitro aged oocytes.

3.2. AUR Recovers Mitochondrial Dysfunction in Postovulatory Aged Oocytes

Mitochondrial dynamics is an important source of ATP production within both oocytes and embryos and is closely related to oxidative stress [23]. Therefore, we tested the activity and function of mitochondria following postovulatory aging by evaluating the distribution pattern and ΔΨm. Normal oocytes showed even dispersion throughout the cytoplasm and accumulated around the chromosomes, while oocytes aged in vitro showed an uneven distribution with large cluster aggregates in the cytoplasm (Figure 2a). These abnormal distribution patterns were significantly reduced in the 1 μM AUR-treated group but not in the 10 μM AUR group (Figure 2b).
When the cationic fluorescent dye JC-1 encounters a high membrane potential, it accumulates inside the mitochondria, aggregates in a concentration-dependent manner and appears red. In contrast, at low membrane potential, JC-1 is present as a monomer and appears green (Figure 3a). Quantitative analysis revealed that the ratio of red to green fluorescence significantly decreased in aged oocytes but this ratio was rescued, i.e., increased, in AUR-treated oocytes (Figure 3b). These results indicate that AUR administration during postovulatory aging can help oocytes maintain normal mitochondrial activity and function.

3.3. AUR Decreases the Intracellular ROS Level and Increases the GSH Level in Aged Oocytes

Oxidative stress has been considered a key mechanism underlying cellular aging [15]. To evaluate the potential of AUR to protect oocytes from oxidative stress during postovulatory aging, we measured the levels of intracellular ROS in postovulatory aged oocytes with DCFH-DA. As shown in Figure 4a,b, the ROS levels in aged oocytes were significantly higher than those in young oocytes, while aged oocytes in the presence of AUR had significantly reduced ROS levels. GSH is an important intracellular antioxidant that eliminates ROS in oocytes [24], so the level of GSH was detected by CMF2HC dye.
The intracellular GSH level in aged oocytes was significantly lower than that in young oocytes, but the GSH content in the aged groups treated with AUR was significantly higher than that in the untreated aged group (Figure 4a,c). These observations suggested that AUR is able to reverse the oxidative damage caused by ROS accumulation and the lack of GSH during postovulatory aging.

3.4. AUR Reduces Oxidative Stress by Regulating the NRF2 Pathway in Aged Oocytes

In vitro postovulatory aging is accompanied by excessive ROS formation, and antioxidant deficiency may lead to oxidative stress. Given the important role of NRF2 as a key regulator of the antioxidant defense system against oxidative stress [20], we examined the relative mRNA expression of Nrf2 and its target genes that are related to the antioxidant defense system in oocytes. Notably, the expression of NRF2 at the transcript and protein levels in the aged group was significantly decreased compared with that in the young group, but the AUR-treated aged group displayed significantly increased levels (Figure 5a,b). However, the transcript level of Keap1, which represses Nrf2 gene transcription, did not differ between the young and aged groups (Figure 5c). When examining the expression of genes involved in primary antioxidant cellular defense, the transcripts of Gclm, Gpx1, Sod1 and Nqo1 were significantly decreased in the aged group compared with the young group, and the AUR-treated aged group had significantly increased mRNA levels of these genes, with the exception of Nqo1 (Figure 5d–h). These results suggest that the generation of oxidative stress during postovulatory aging is relieved by activating antioxidative effects through the NRF2 signaling pathway under the effect of AUR.

3.5. AUR Improves the Fertilization and Preimplantation Embryo Development Potential of Postovulatory Aged Oocytes

Above, we confirmed that AUR improves the quality of aged oocytes; therefore, we also tried to determine whether AUR affects fertilization and embryo development. As shown in Figure 6a–c, in the young group, 57.8% of the oocytes could develop into 2-cell (2C) embryos, and 55% could develop to the blastocyst stage. For 12 h aged oocytes, the proportions of 2C and blastocyst embryos decreased to 13.6% and 1.6%, respectively. However, in the AUR 1 μM- or 10 μM-supplemented aged oocyte group, the proportions of 2C embryos (47.6% and 35%, respectively) and blastocyst formation (26% and 12.5%, respectively) were significantly increased (Figure 6a–c).
Additionally, a time-lapse imaging system was used to assess the morphology and timing of successive divisions, compaction and blastocoel formation during embryo development. The results of the time-lapse imaging system were analyzed, with fertilized embryos showing 2PN. Therefore, the number of n in each group was different depending on the fertilization rate (n = 65, 12, 60, 25 embryos in each group). In the case of aged oocytes, the fertilization rate was low, and the number of embryos was small. In embryos derived from aged oocytes, the cleavage time from t3 to t5, CC2 (t3-t2) and CC3 (t5-t3) were significantly increased compared to embryos from young oocytes (Figure 7c–q) and resulted in failure to develop to the blastocyst stage with an increased incidence of unequal-sized blastomeres, developmental arrest and fragmentation (Figure 7a,b, Video S1).
The morphokinetic parameters of the embryos from aged oocytes with 1 μM AUR treatment were comparable to those of embryos from young oocytes with no statistically significant difference (Figure 7c–q, Video S1). However, the embryos from aged oocytes with 10 μM AUR were able to form a blastocyst, but the cleavage time was longer than that of the embryos from young oocytes. Additionally, these blastocysts mostly underwent cell exclusion during compaction, excluding cell fragments not participating in blastocyst formation [25], and did not develop to a sufficient size for subsequent expansion or hatching (Figure 7a,b, Video S2). Collectively, these results suggest that 1 μM AUR can delay postovulatory aging and improve the fertilization and early embryonic development of aging oocytes.

4. Discussion

Postovulatory aging in vitro is an important detrimental cause of failure in ART procedures. The age-related decline in oocyte quality compromises subsequent fertilization and embryo development. Therefore, in the current study, we investigated whether the antioxidant AUR can effectively improve the quality of aged oocytes to increase the fertilization success rate and further embryo development. We applied particular focus to relieving oxidative stress as a major contributor to the aging of oocytes. AUR, a well-known coumarin is well known as an outstanding antioxidant with radical scavenger activities. Antioxidative activity of AUR is higher than reference substances (Ascorbic acid and Trolox®) [4]. AUR with antioxidant activities has been acknowledged in several studies using other experimental models [26]. The anti-inflammatory and antioxidative effects of AUR also increased oocyte maturation and the fertilization rates of oocytes in an in vivo polycystic ovarian syndrome (PCOS) model [27]. AUR inhibited ROS generation and enhanced mitochondrial respiration through induction of NRF2 in a Parkinson’s disease mouse model [28] and activated antioxidant enzymes and the mitochondrial unfolded protein response, which improves junction assembly in cerebrovascular endothelial cells [29]. AUR also induced hepatic GST and NQO1 by activating the antioxidant response in Nrf2 knockout mice [30]. Moreover, Hassanein and colleagues explained the pharmacological and therapeutic effects of coumarins related to antioxidation in the KEAP1-NRF2-ARE signaling pathway [31]. Furthermore, Nrf2 deletion was associated with a wide variety of pathologies, including aging and age-related diseases [20,32]. NRF2 localizes around the meiotic spindle and is associated with the proper formation or stabilization of the spindle, and its expression is significantly decreased in aged oocytes, resulting in the loss of GSH synthesis [33]. In addition, accumulating studies have indicated that the activation of NRF2 signaling could be a potential regulator to suppress oxidative stress to normalize reproductive functions [34,35].
Thus, we hypothesized that supplementing culture media with the antioxidant AUR might prevent postovulatory aging by suppressing oxidative stress through the modulation pf NRF2 signaling. AUR has never been tested before in in vitro oocyte culture, so we used concentrations of 1 μM and 10 μM in the culture medium with different cell lines to show its pharmacological effects [36,37]. We first assessed the meiotic spindle assembly and chromosome alignment of postovulatory aged oocytes with or without AUR. Meiotic chromosomes contain the oocyte’s genetic information, and an intact meiotic spindle is responsible for the correct segregation of chromosomes. Additionally, it was reported that 12 h aged oocytes interfered with the proper involvement of the spindle assembly checkpoint (SAC) transcripts and functional proteins and exhibited aneuploidy, which occurs in aged oocytes or early embryonic developmental stages at the same frequency [38]. In line with previous observations, we confirmed that the spindle changes abnormally during oocyte aging, but we found that aged oocytes retain normal spindle and chromosome structures after AUR supplementation. In addition, we also analyzed mitochondrial activity and functions in aged oocytes. Oocyte mitochondria are the organelles that generate ATP via oxidative phosphorylation, contribute to biosynthesis, and control redox homeostasis during oocyte maturation, fertilization, and embryo development. These mitochondrial activities must be supported in mature oocytes and embryos [39]. Previous studies have shown that changes in the distribution and function of mitochondria are associated with aging [40]. Our data demonstrated that AUR protects the function of the mitochondria by rescuing mitochondrial distribution patterns and increasing the membrane potential. Therefore, we determined that AUR could improve oocyte quality during postovulatory aging in vitro.
As a major cause of oxidative stress, aged oocytes exhibit susceptibility to raised ROS levels and concomitantly decreased antioxidant protection. GSH is the most plentiful antioxidant in cells and impacts cytoplasmic maturation, correlating with oocyte fertilization and subsequent development [41]. It has also been reported that the level of GSH is lower in postovulatory aged mouse oocytes [17]. Consistent with previous studies, we observed that AUR significantly diminished the levels of intracellular ROS while increasing GSH contents within in vitro aged oocytes, indicating that AUR alleviates oxidative stress in aged oocytes. Additionally, to track the mechanism of the antioxidative activities of AUR, we detected the expression of NRF2 and its downstream antioxidant enzymes. Indeed, the NRF2 pathway plays a significant role in activating the response to oxidative stress. ROS scavenging enzymes such as SOD1 and GPx1 are front-line mediators of redox equilibrium [42]. SOD1 is associated with the suppression of segregation defects during aging in oocytes [43], and GPx reinforces oocyte and embryo developmental capacity [44]. In addition, knockout of Gclm, the regulatory subunit that constitutes the GCL complex, which is the rate-limiting step in the synthesis of GSH, causes litter size reduction by damaging embryo viability during early embryonic development [45]. Thus, increasing the expression of these antioxidant enzymes is important to protect oocytes and embryos from oxidative stress brought about by aging. In our study, we confirmed that the expression levels of Nrf2 and antioxidant enzyme genes (Sod1, Gpx1, Gclc, Gclm, and Nqo1) decreased under in vitro aging conditions and but increased after AUR treatment. These results indicate the potential mechanisms of the anti-aging effects of AUR through NRF2-mediated antioxidant signaling pathways, effectively removing ROS in postovulatory aged oocytes.
Decreases in the fertilization and preimplantation embryo development rates can be attributed to multiple biochemical and functional alterations to the oocyte that accumulate with postovulatory aging [14]. We investigated the effect of AUR on the fertilization and embryonic development rates of in vitro postovulatory aged oocytes and evaluated the morphokinetic parameters of preimplantation embryos using time-lapse imaging. Continuous noninvasive monitoring of embryo development allows the selection of embryos with the best implantation potential for ART [46]. Moreover, the morphokinetic parameters provide sensitive indicator of quality of embryos culture in vitro [47]. In this study, the fertilization rate of the aged oocytes was greatly reduced, and even after fertilization, the timing of cleavage was delayed, and development to the blastocyst stage rarely occurred. Embryos from aged oocytes degenerated by showing several morphologies, including arrest, irregular divisions, and fragment formation. These factors also negatively correlate with embryo development and implantation [48]. In aged oocytes treated with both concentrations of AUR, the fertilization rate and embryonic development rate were higher than those in aged oocytes. However, this situation was different depending on the concentration of AUR. In aged oocytes administered 10 μM AUR, the embryos formed blastocysts, unlike aged oocytes without AUR, but development took longer, particularly for tErB. It seems likely that cell exclusion occurred at the cavitation of morula stage embryos or extrusion at the postcompaction stage, so the embryo did not grow to a full size that was large enough to expand or escape from the zona pellucida to hatch. Cell exclusion during compaction (morula stage) or later at the blastulation stage is an attempt to self-correct by putting out cells that may be mosaic. However, embryos that exclude cells early in development would have higher aneuploidy than late exclusion embryos [49]. On the other hand, with 1 μM AUR, embryo development was relatively shorter and not different from that in the young oocyte group. Therefore, these results indicated that 1 μM AUR has the potential to improve the quality of aged oocytes after ovulation, the fertilization rate and embryonic development.
ART is the only way to effectively solve the problems of infertile patients that are produced by a variety of factors. Nevertheless, to reduce the risk of ART failure, there is a need for a series of clinical trials involving the development of a strategy to gain time to protect gametes and embryos from oxidative stress. Attempts have been made to minimize oxidative stress by supplementation with antioxidants. Factually, supplementation with natural antioxidants such as melatonin, coenzyme Q10 (CoQ10), resveratrol, vitamins, etc., has already been reported in in vitro and in vivo studies using animal models as well as human clinical studies. Following is a brief summary of the characteristics of some of these antioxidants. First, melatonin improves oocyte quality through the direct scavenging of ROS and indirect action-mediated receptors [50]. The concentrations of melatonin increased in ovarian follicular fluid and oocytes to reduce oxidative stress in infertile patients after in vivo administration [51]. The clinical application of melatonin has been shown to have a good influence on human oocyte maturation, fertilization and embryo development rates [52]. On the other hand, melatonin showed no significant impact on the number of MII oocytes, clinical pregnancy rate, or numbers of live births or miscarriages [53]. CoQ10, an electron carrier in the mitochondrial respiration chain, improves the quality of oocytes by reducing oxidative stress and enhancing mitochondrial function in animal models [54]. In human clinical studies, oral CoQ10 supplementation increased the number of mature follicles and established a more appropriate environment for follicle development [55,56]. However, these factors bring about no significant differences in pregnancy, miscarriage, or live birth rates [57]. Rather, during in vitro maturation, the addition of either CoQ10 or MitoQ (a CoQ10 analog) to culture media can increase maturation rates and improve the quality of human oocytes by reducing aneuploidy rates [58] or decreasing chromosomal defects [59], respectively. Resveratrol has been studied for its beneficial effects on oocyte maturation and embryo development in experimental models [60,61]. However, there is a dearth of information from human IVF data. Bahramrezaie et al. [62] conducted a randomized controlled trial in which sixty-two infertile PCOS patients received 800 mg/day resveratrol orally for 40 days. As a result, the high-quality oocyte and embryo rates were higher in the resveratrol supplementation group and the expression of the VEGF and HIF1 genes was reduced in granulosa cells through the angiogenesis pathway of granulosa cells [62]. Nevertheless, it is understood that resveratrol also inhibits decidualization in the uterine endometrium, so its intake should be avoided after ovulation and during pregnancy [63]. There is also limited clinical information regarding vitamins. Several studies have investigated whether vitamins play an important role as antioxidants by evaluating the correlation between the levels of vitamins in the serum or follicular fluid and IVF outcomes [64,65].
Similarly, although it is still difficult to validate the outcomes obtained using animal models, the development of therapies and clinical applications using safe and promising antioxidants is important and should be continuously required in the reproductive field. Here, our findings demonstrated that AUR may assist as another antioxidant supplements to the culture media of oocyte for improving oocyte and embryo quality. This suggests that treating oocytes with AUR in the culture media can allow more time for successful fertilization and embryo development.

5. Conclusions

As the time that ovulated oocytes are exposed to an in vitro environment without sperm activation increases, the quality of the ovulated oocytes decreases through the aging process. AUR may be resolved the oocyte aging by providing safe interventional strategies with natural antioxidative compound. In the present study, we confirmed that AUR had positive effects on postovulatory aged oocytes, diminished free radicals and activated the antioxidant system controlling the NRF2 pathway, thereby moderating oxidative stress and consequently improving fertilization and embryonic development (Figure 8). Therefore, we propose that AUR could be a novel and effective candidate for delaying the aging process in oocytes, and in particular, the utility of antioxidants during ART techniques.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/antiox12010087/s1: Video S1: Comparison of embryo development, Video S2: Cell exclusion.

Author Contributions

Conceptualization, S.-Y.L., M.-K.K. and K.-A.L.; methodology, Y.-H.K., S.-Y.L., E.-Y.K. and K.-H.K.; formal analysis, Y.-H.K., S.-Y.L. and K.-H.K.; data curation, Y.-H.K., S.-Y.L., E.-Y.K., K.-H.K. and K.-A.L.; writing—original draft preparation, Y.-H.K. and K.-A.L.; visualization, Y.-H.K.; supervision, M.-K.K. and K.-A.L.; project administration, K.-A.L.; and funding acquisition, M.-K.K. and K.-A.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (no. 2022R1A2C1006672) and the LG Chem Life Sciences Headquarters R&D Grant Team.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Animal Care and Use Committee of CHA University (approval no. IACUC220083).

Informed Consent Statement

Not applicable.

Data Availability Statement

All the data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bibak, B.; Shakeri, F.; Barreto, G.E.; Keshavarzi, Z.; Sathyapalan, T.; Sahebkar, A. A review of the pharmacological and therapeutic effects of auraptene. Biofactors 2019, 45, 867–879. [Google Scholar] [CrossRef] [PubMed]
  2. Askari, V.R.; Rahimi, V.B.; Rezaee, S.A.; Boskabady, M.H. Auraptene regulates Th1/Th2/TReg balances, NF-kappaB nuclear localization and nitric oxide production in normal and Th2 provoked situations in human isolated lymphocytes. Phytomedicine 2018, 43, 1–10. [Google Scholar] [CrossRef] [PubMed]
  3. Askari, V.R.; Rahimi, V.B.; Zargarani, R.; Ghodsi, R.; Boskabady, M.; Boskabady, M.H. Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes. Pharmacol. Rep. 2021, 73, 154–162. [Google Scholar] [CrossRef] [PubMed]
  4. Fiorito, S.; Epifano, F.; Palumbo, L.; Genovese, S. A novel auraptene-enriched citrus peels-based blend with enhanced antioxidant activity. Plant Foods Hum. Nutr. 2021, 76, 397–398. [Google Scholar] [CrossRef] [PubMed]
  5. Keshavarzi, Z.; Amiresmaili, S.; Shahrokhi, N.; Bibak, B.; Shakeri, F. Neuroprotective effects of auraptene following traumatic brain injury in male rats: The role of oxidative stress. Brain Res. Bull. 2021, 177, 203–209. [Google Scholar] [CrossRef]
  6. Tayarani-Najaran, Z.; Tayarani-Najaran, N.; Eghbali, S. A review of auraptene as an anticancer agent. Front. Pharmacol. 2021, 12, 698352. [Google Scholar] [CrossRef]
  7. Vakili, T.; Iranshahi, M.; Arab, H.; Riahi, B.; Roshan, N.M.; Karimi, G. Safety evaluation of auraptene in rats in acute and subacute toxicity studies. Regul. Toxicol. Pharmacol. 2017, 91, 159–164. [Google Scholar] [CrossRef]
  8. Igase, M.; Okada, Y.; Ochi, M.; Igase, K.; Ochi, H.; Okuyama, S.; Furukawa, Y.; Ohyagi, Y. Auraptene in the Peels of Citrus Kawachiensis (Kawachibankan) Contributes to the Preservation of Cognitive Function: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers. J. Prev. Alzheimers. Dis. 2018, 5, 197–201. [Google Scholar] [CrossRef]
  9. Galluzzi, S.; Zanardini, R.; Ferrari, C.; Gipponi, S.; Passeggia, I.; Rampini, M.; Sgro, G.; Genovese, S.; Fiorito, S.; Palumbo, L.; et al. Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: A 36-week, randomized, placebo-controlled trial. Nutr. J. 2022, 21, 64. [Google Scholar] [CrossRef]
  10. Miao, Y.L.; Kikuchi, K.; Sun, Q.Y.; Schatten, H. Oocyte aging: Cellular and molecular changes, developmental potential and reversal possibility. Hum. Reprod. Update 2009, 15, 573–585. [Google Scholar] [CrossRef]
  11. Prasad, S.; Tiwari, M.; Koch, B.; Chaube, S.K. Morphological, cellular and molecular changes during postovulatory egg aging in mammals. J. Biomed. Sci. 2015, 22, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Trapphoff, T.; Heiligentag, M.; Dankert, D.; Demond, H.; Deutsch, D.; Frohlich, T.; Arnold, G.J.; Grummer, R.; Horsthemke, B.; Eichenlaub-Ritter, U. Postovulatory aging affects dynamics of mRNA, expression and localization of maternal effect proteins, spindle integrity and pericentromeric proteins in mouse oocytes. Hum. Reprod. 2016, 31, 133–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Igarashi, H.; Takahashi, T.; Abe, H.; Nakano, H.; Nakajima, O.; Nagase, S. Poor embryo development in post-ovulatory in vivo-aged mouse oocytes is associated with mitochondrial dysfunction, but mitochondrial transfer from somatic cells is not sufficient for rejuvenation. Hum. Reprod. 2016, 31, 2331–2338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Martin, J.H.; Bromfield, E.G.; Aitken, R.J.; Nixon, B. Biochemical alterations in the oocyte in support of early embryonic development. Cell Mol. Life Sci. 2017, 74, 469–485. [Google Scholar] [CrossRef]
  15. Lord, T.; Aitken, R.J. Oxidative stress and ageing of the post-ovulatory oocyte. Reproduction 2013, 146, R217–R227. [Google Scholar] [CrossRef] [Green Version]
  16. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47–95. [Google Scholar] [CrossRef] [Green Version]
  17. Di Nisio, V.; Antonouli, S.; Damdimopoulou, P.; Salumets, A.; Cecconi, S.; Sierr. In vivo and in vitro postovulatory aging: When time works against oocyte quality? J. Assist. Reprod. Genet. 2022, 39, 905–918. [Google Scholar] [CrossRef]
  18. Agarwal, A.; Durairajanayagam, D.; du Plessis, S.S. Utility of antioxidants during assisted reproductive techniques: An evidence based review. Reprod. Biol. Endocrinol. 2014, 12, 112. [Google Scholar] [CrossRef] [Green Version]
  19. Tonelli, C.; Chio, I.I.C.; Tuveson, D.A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 2018, 29, 1727–1745. [Google Scholar] [CrossRef] [Green Version]
  20. Yu, C.; Xiao, J.H. The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging. Oxid. Med. Cell Longev. 2021, 2021, 6635460. [Google Scholar] [CrossRef]
  21. Zhou, D.; Shen, X.; Gu, Y.; Zhang, N.; Li, T.; Wu, X.; Lei, L. Effects of dimethyl sulfoxide on asymmetric division and cytokinesis in mouse oocytes. BMC Dev Biol. 2014, 14, 28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Kim, K.H.; Kim, E.Y.; Lee, K.A. GAS6 ameliorates advanced age-associated meiotic defects in mouse oocytes by modulating mitochondrial function. Aging 2021, 13, 18018–18032. [Google Scholar] [CrossRef] [PubMed]
  23. Almansa-Ordonez, A.; Bellido, R.; Vassena, R.; Barragan, M.; Zambelli, F. Oxidative stress in reproduction: A mitochondrial perspective. Biology 2020, 9, 269. [Google Scholar] [CrossRef] [PubMed]
  24. Khazaei, M.; Aghaz, F. Reactive Oxygen Species Generation and Use of Antioxidants during In Vitro Maturation of Oocytes. Int. J. Fertil Steril 2017, 11, 63–70. [Google Scholar] [CrossRef]
  25. Cecchele, A.; Cermisoni, G.C.; Giacomini, E.; Pinna, M.; Vigano, P. Cellular and molecular nature of fragmentation of human embryos. Int. J. Mol. Sci. 2022, 23, 1349. [Google Scholar] [CrossRef]
  26. Bubols, G.B.; Dda, R.V.; Medina-Remon, A.; von Poser, G.; Lamuela-Raventos, R.M.; Eifler-Lima, V.L.; Garcia, S.C. The antioxidant activity of coumarins and flavonoids. Mini Rev. Med. Chem. 2013, 13, 318–334. [Google Scholar] [CrossRef]
  27. Abizadeh, M.; Novin, M.G.; Amidi, F.; Ziaei, S.A.; Abdollahifar, M.A.; Nazarian, H. Potential of auraptene in improvement of oocyte maturation, fertilization rate, and inflammation in polycystic ovary syndrome mouse model. Reprod. Sci. 2020, 27, 1742–1751. [Google Scholar] [CrossRef]
  28. Jang, Y.; Choo, H.; Lee, M.J.; Han, J.; Kim, S.J.; Ju, X.; Cui, J.; Lee, Y.L.; Ryu, M.J.; Oh, E.S.; et al. Auraptene mitigates Parkinson’s disease-like behavior by protecting inhibition of mitochondrial respiration and scavenging reactive oxygen species. Int. J. Mol. Sci. 2019, 20, 3409. [Google Scholar] [CrossRef] [Green Version]
  29. Lee, M.J.; Jang, Y.; Zhu, J.; Namgung, E.; Go, D.; Seo, C.; Ju, X.; Cui, J.; Lee, Y.L.; Kang, H.; et al. Auraptene Enhances Junction Assembly in Cerebrovascular Endothelial Cells by Promoting Resilience to Mitochondrial Stress through Activation of Antioxidant Enzymes and mtUPR. Antioxidants 2021, 10, 475. [Google Scholar] [CrossRef]
  30. Prince, M.; Li, Y.; Childers, A.; Itoh, K.; Yamamoto, M.; Kleiner, H.E. Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice. Toxicol. Lett. 2009, 185, 180–186. [Google Scholar] [CrossRef]
  31. Hassanein, E.H.M.; Sayed, A.M.; Hussein, O.E.; Mahmoud, A.M. Coumarins as modulators of the Keap1/Nrf2/ARE signaling pathway. Oxidative Med. Cell Longev. 2020, 2020, 1675957. [Google Scholar] [CrossRef] [Green Version]
  32. Lewis, K.N.; Wason, E.; Edrey, Y.H.; Kristan, D.M.; Nevo, E.; Buffenstein, R. Regulation of Nrf2 signaling and longevity in naturally long-lived rodents. Proc. Natl. Acad. Sci. USA 2015, 112, 3722–3727. [Google Scholar] [CrossRef] [Green Version]
  33. Ma, R.; Liang, W.; Sun, Q.; Qiu, X.; Lin, Y.; Ge, X.; Jueraitetibaike, K.; Xie, M.; Zhou, J.; Huang, X.; et al. Sirt1/Nrf2 pathway is involved in oocyte aging by regulating Cyclin B1. Aging 2018, 10, 2991–3004. [Google Scholar] [CrossRef] [PubMed]
  34. Akino, N.; Wada-Hiraike, O.; Isono, W.; Terao, H.; Honjo, H.; Miyamoto, Y.; Tanikawa, M.; Sone, K.; Hirano, M.; Harada, M.; et al. Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary. Reprod. Biol. Endocrinol. 2019, 17, 23. [Google Scholar] [CrossRef] [PubMed]
  35. Fonseca, E.; Marques, C.C.; Pimenta, J.; Jorge, J.; Baptista, M.C.; Goncalves, A.C.; Pereira, R. Anti-aging effect of urolithin a on bovine oocytes in vitro. Animals 2021, 11, 2048. [Google Scholar] [CrossRef] [PubMed]
  36. Lin, S.; Hirai, S.; Goto, T.; Sakamoto, T.; Takahashi, N.; Yano, M.; Sasaki, T.; Yu, R.; Kawada, T. Auraptene suppresses inflammatory responses in activated RAW264 macrophages by inhibiting p38 mitogen-activated protein kinase activation. Mol. Nutr. Food Res. 2013, 57, 1135–1144. [Google Scholar] [CrossRef] [PubMed]
  37. Furukawa, Y.; Washimi, Y.S.; Hara, R.I.; Yamaoka, M.; Okuyama, S.; Sawamoto, A.; Nakajima, M. Citrus auraptene induces expression of brain-derived neurotrophic factor in Neuro2a cells. Molecules 2020, 25, 1117. [Google Scholar] [CrossRef] [Green Version]
  38. Shimoi, G.; Tomita, M.; Kataoka, M.; Kameyama, Y. Destabilization of spindle assembly checkpoint causes aneuploidy during meiosis II in murine post-ovulatory aged oocytes. J. Reprod. Dev. 2019, 65, 57–66. [Google Scholar] [CrossRef] [Green Version]
  39. Zhang, D.; Keilty, D.; Zhang, Z.F.; Chian, R.C. Mitochondria in oocyte aging: Current understanding. Facts Views Vis. Obgyn 2017, 9, 29–38. [Google Scholar]
  40. van der Reest, J.; Cecchino, G.N.; Haigis, M.C.; Kordowitzki, P. Mitochondria: Their relevance during oocyte ageing. Ageing Res. Rev. 2021, 70, 101378. [Google Scholar] [CrossRef]
  41. Maedomari, N.; Kikuchi, K.; Ozawa, M.; Noguchi, J.; Kaneko, H.; Ohnuma, K.; Nakai, M.; Shino, M.; Nagai, T.; Kashiwazaki, N. Cytoplasmic glutathione regulated by cumulus cells during porcine oocyte maturation affects fertilization and embryonic development in vitro. Theriogenology 2007, 67, 983–993. [Google Scholar] [CrossRef] [PubMed]
  42. Lu, J.; Wang, Z.; Cao, J.; Chen, Y.; Dong, Y. A novel and compact review on the role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 2018, 16, 80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Perkins, A.T.; Greig, M.M.; Sontakke, A.A.; Peloquin, A.S.; McPeek, M.A.; Bickel, S.E. Increased levels of superoxide dismutase suppress meiotic segregation errors in aging oocytes. Chromosoma 2019, 128, 215–222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Ufer, C.; Wang, C.C. The roles of glutathione peroxidases during embryo development. Front. Mol. Neurosci. 2011, 4, 12. [Google Scholar] [CrossRef] [Green Version]
  45. Nakamura, B.N.; Fielder, T.J.; Hoang, Y.D.; Lim, J.; McConnachie, L.A.; Kavanagh, T.J.; Luderer, U. Lack of maternal glutamate cysteine ligase modifier subunit (Gclm) decreases oocyte glutathione concentrations and disrupts preimplantation development in mice. Endocrinology 2011, 152, 2806–2815. [Google Scholar] [CrossRef]
  46. Armstrong, S.; Bhide, P.; Jordan, V.; Pacey, A.; Marjoribanks, J.; Farquhar, C. Time-lapse systems for embryo incubation and assessment in assisted reproduction. Cochrane Database Syst. Rev. 2019, 5, CD011320. [Google Scholar] [CrossRef]
  47. Wolff, H.S.; Fredrickson, J.R.; Walker, D.L.; Morbeck, D.E. Advances in quality control: Mouse embryo morphokinetics are sensitive markers of in vitro stress. Hum. Reprod. 2013, 28, 1776–1782. [Google Scholar] [CrossRef] [Green Version]
  48. Aparicio, B.; Cruz, M.; Meseguer, M. Is morphokinetic analysis the answer? Reprod. Biomed. Online 2013, 27, 654–663. [Google Scholar] [CrossRef] [Green Version]
  49. Lagalla, C.; Coticchio, G.; Sciajno, R.; Tarozzi, N.; Zaca, C.; Borini, A. Alternative patterns of partial embryo compaction: Prevalence, morphokinetic history and possible implications. Reprod. Biomed. Online 2020, 40, 347–354. [Google Scholar] [CrossRef]
  50. Tamura, H.; Jozaki, M.; Tanabe, M.; Shirafuta, Y.; Mihara, Y.; Shinagawa, M.; Tamura, I.; Maekawa, R.; Sato, S.; Taketani, T.; et al. Importance of melatonin in assisted reproductive technology and ovarian aging. Int. J. Mol. Sci. 2020, 21, 1135. [Google Scholar] [CrossRef] [Green Version]
  51. Tamura, H.; Takasaki, A.; Miwa, I.; Taniguchi, K.; Maekawa, R.; Asada, H.; Taketani, T.; Matsuoka, A.; Yamagata, Y.; Shimamura, K.; et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J. Pineal Res. 2008, 44, 280–287. [Google Scholar] [CrossRef] [PubMed]
  52. Yong, W.; Ma, H.; Na, M.; Gao, T.; Zhang, Y.; Hao, L.; Yu, H.; Yang, H.; Deng, X. Roles of melatonin in the field of reproductive medicine. Biomed. Pharmacother. 2021, 144, 112001. [Google Scholar] [CrossRef] [PubMed]
  53. Fernando, S.; Wallace, E.M.; Vollenhoven, B.; Lolatgis, N.; Hope, N.; Wong, M.; Lawrence, M.; Lawrence, A.; Russell, C.; Leong, K.; et al. Melatonin in assisted reproductive technology: A pilot double-blind randomized placebo-controlled clinical trial. Front. Endocrinol. 2018, 9, 545. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Rodriguez-Varela, C.; Labarta, E. Does coenzyme Q10 supplementation improve human oocyte quality? Int. J. Mol. Sci. 2021, 22, 9541. [Google Scholar] [CrossRef]
  55. Gat, I.; Mejia, S.B.; Balakier, H.; Librach, C.L.; Claessens, A.; Ryan, E.A. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve. Gynecol. Endocrinol. 2016, 32, 534–537. [Google Scholar] [CrossRef]
  56. Giannubilo, S.R.; Orlando, P.; Silvestri, S.; Cirilli, I.; Marcheggiani, F.; Ciavattini, A.; Tiano, L. CoQ10 supplementation in patients undergoing IVF-ET: The relationship with follicular fluid content and oocyte maturity. Antioxidants 2018, 7, 141. [Google Scholar] [CrossRef] [Green Version]
  57. Xu, Y.; Nisenblat, V.; Lu, C.; Li, R.; Qiao, J.; Zhen, X.; Wang, S. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: A randomized controlled trial. Reprod. Biol. Endocrinol. 2018, 16, 29. [Google Scholar] [CrossRef] [Green Version]
  58. Ma, L.; Cai, L.; Hu, M.; Wang, J.; Xie, J.; Xing, Y.; Shen, J.; Cui, Y.; Liu, X.J.; Liu, J. Coenzyme Q10 supplementation of human oocyte in vitro maturation reduces postmeiotic aneuploidies. Fertil. Steril. 2020, 114, 331–337. [Google Scholar] [CrossRef]
  59. Al-Zubaidi, U.; Adhikari, D.; Cinar, O.; Zhang, Q.H.; Yuen, W.S.; Murphy, M.P.; Rombauts, L.; Robker, R.L.; Carroll, J. Mitochondria-targeted therapeutics, MitoQ and BGP-15, reverse aging-associated meiotic spindle defects in mouse and human oocytes. Hum. Reprod. 2021, 36, 771–784. [Google Scholar] [CrossRef]
  60. Lee, S.; Jin, J.X.; Taweechaipaisankul, A.; Kim, G.A.; Lee, B.C. Synergistic effects of resveratrol and melatonin on in vitro maturation of porcine oocytes and subsequent embryo development. Theriogenology 2018, 114, 191–198. [Google Scholar] [CrossRef]
  61. Sun, Y.L.; Tang, S.B.; Shen, W.; Yin, S.; Sun, Q.Y. Roles of resveratrol in improving the quality of postovulatory aging oocytes in vitro. Cells 2019, 8, 1132. [Google Scholar] [CrossRef] [PubMed]
  62. Bahramrezaie, M.; Amidi, F.; Aleyasin, A.; Saremi, A.; Aghahoseini, M.; Brenjian, S.; Khodarahmian, M.; Pooladi, A. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: A triple-blind randomized clinical trial. J. Assist. Reprod. Genet. 2019, 36, 1701–1712. [Google Scholar] [CrossRef] [PubMed]
  63. Ochiai, A.; Kuroda, K. Preconception resveratrol intake against infertility: Friend or foe? Reprod. Med. Biol. 2020, 19, 107–113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Bahadori, M.H.; Sharami, S.H.; Fakor, F.; Milani, F.; Pourmarzi, D.; Dalil-Heirati, S.F. Level of vitamin E in follicular fluid and serum and oocyte morphology and embryo quality in patients undergoing IVF treatment. J. Family Reprod. Health 2017, 11, 74–81. [Google Scholar]
  65. Lu, X.; Wu, Z.; Wang, M.; Cheng, W. Effects of vitamin C on the outcome of in vitro fertilization-embryo transfer in endometriosis: A randomized controlled study. J. Int. Med. Res. 2018, 46, 4624–4633. [Google Scholar] [CrossRef]
Antioxidants 12 00087 g001 550
Figure 1. AUR protected the organizational dynamics of spindles and chromosomes during postovulatory aging. (a) A schematic diagram to illustrate the experimental design to investigate how AUR impact postovulatory aged oocytes. (b) Representative images of meiotic spindles and chromosomes in young and aged oocytes with or without AUR administration. Spindles were stained with α-tubulin (a spindle marker, green), and chromosomes were stained with DAPI (DNA, blue); scale bar = 20 μm. (c) Lengths of the spindles in each group of oocytes. Dots of boxplot show individual values of each observation. (d) Percentages of abnormal spindles in oocytes in each group. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.05, * p < 0.05, *** p < 0.001.
Figure 1. AUR protected the organizational dynamics of spindles and chromosomes during postovulatory aging. (a) A schematic diagram to illustrate the experimental design to investigate how AUR impact postovulatory aged oocytes. (b) Representative images of meiotic spindles and chromosomes in young and aged oocytes with or without AUR administration. Spindles were stained with α-tubulin (a spindle marker, green), and chromosomes were stained with DAPI (DNA, blue); scale bar = 20 μm. (c) Lengths of the spindles in each group of oocytes. Dots of boxplot show individual values of each observation. (d) Percentages of abnormal spindles in oocytes in each group. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.05, * p < 0.05, *** p < 0.001.
Antioxidants 12 00087 g001
Antioxidants 12 00087 g002 550
Figure 2. AUR affected mitochondrial distribution during postovulatory aging. (a) Representative images of mitochondrial distribution in young and aged oocytes with or without AUR administration. Oocytes were stained with MitoTracker (mitochondria marker, red), and chromosomes were stained with DAPI (DNA, blue); scale bar = 100 μm. (b) Percentages of abnormal mitochondrial distribution in each group of oocytes. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.001.
Figure 2. AUR affected mitochondrial distribution during postovulatory aging. (a) Representative images of mitochondrial distribution in young and aged oocytes with or without AUR administration. Oocytes were stained with MitoTracker (mitochondria marker, red), and chromosomes were stained with DAPI (DNA, blue); scale bar = 100 μm. (b) Percentages of abnormal mitochondrial distribution in each group of oocytes. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.001.
Antioxidants 12 00087 g002
Antioxidants 12 00087 g003 550
Figure 3. AUR enhanced mitochondrial function by raising ΔΨm during postovulatory aging. (a) Representative images of mitochondrial ΔΨm in young and aged oocytes with or without AUR administration. Oocytes were stained with the cationic dye JC-1, which can selectively enter mitochondria and reversibly turn the emitted green fluorescence into red depending upon the mitochondrial membrane potential (aggregated JC-1: high potential marker, red; monomeric JC-1: low potential marker, green); scale bar = 20 μm. (b) The ratio of red to green fluorescence intensity in each group of oocytes. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.001.
Figure 3. AUR enhanced mitochondrial function by raising ΔΨm during postovulatory aging. (a) Representative images of mitochondrial ΔΨm in young and aged oocytes with or without AUR administration. Oocytes were stained with the cationic dye JC-1, which can selectively enter mitochondria and reversibly turn the emitted green fluorescence into red depending upon the mitochondrial membrane potential (aggregated JC-1: high potential marker, red; monomeric JC-1: low potential marker, green); scale bar = 20 μm. (b) The ratio of red to green fluorescence intensity in each group of oocytes. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.001.
Antioxidants 12 00087 g003
Antioxidants 12 00087 g004 550
Figure 4. AUR decreased intracellular ROS and elevated GSH during postovulatory aging. (a) Representative images of reactive oxygen species (ROS) and glutathione (GSH) distribution in the oocytes in the Young, POA, POA+AUR 1 μM and POA+AUR 10 μM groups. Oocytes were stained with DCFH-DA (green) or CMF2HC (blue), scale bar = 20 μm. (b) Fluorescence intensities denoting intracellular ROS distribution in oocytes in all groups. (c) Fluorescence intensities of intracellular GSH staining distribution in oocytes in all groups. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.01.
Figure 4. AUR decreased intracellular ROS and elevated GSH during postovulatory aging. (a) Representative images of reactive oxygen species (ROS) and glutathione (GSH) distribution in the oocytes in the Young, POA, POA+AUR 1 μM and POA+AUR 10 μM groups. Oocytes were stained with DCFH-DA (green) or CMF2HC (blue), scale bar = 20 μm. (b) Fluorescence intensities denoting intracellular ROS distribution in oocytes in all groups. (c) Fluorescence intensities of intracellular GSH staining distribution in oocytes in all groups. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.01.
Antioxidants 12 00087 g004
Antioxidants 12 00087 g005 550
Figure 5. AUR upregulated the expression of NRF2-related genes during postovulatory aging. (a,b) Expression patterns of NRF2 mRNA and protein in postovulatory aged oocytes. (c–h) Transcription levels of NRF2-related genes (Keap1, Gclc, Gclm, Gpx1, Sod1 and Nqo1), p < 0.05. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.05.
Figure 5. AUR upregulated the expression of NRF2-related genes during postovulatory aging. (a,b) Expression patterns of NRF2 mRNA and protein in postovulatory aged oocytes. (c–h) Transcription levels of NRF2-related genes (Keap1, Gclc, Gclm, Gpx1, Sod1 and Nqo1), p < 0.05. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.05.
Antioxidants 12 00087 g005
Antioxidants 12 00087 g006 550
Figure 6. AUR promoted the fertilization and preimplantation development of postovulatory aged oocytes. (a) Representative images of blastocysts from young, aged and AUR-treated aged oocytes. Scale bar = 100 μm. (b,c) Quantitative analysis of embryo 2-cell and blastocyst formation rates. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.01.
Figure 6. AUR promoted the fertilization and preimplantation development of postovulatory aged oocytes. (a) Representative images of blastocysts from young, aged and AUR-treated aged oocytes. Scale bar = 100 μm. (b,c) Quantitative analysis of embryo 2-cell and blastocyst formation rates. Data are presented as the means ± SEMs of at least three independent experiments. Significant difference indicated by lowercase letters of the alphabet, p < 0.01.
Antioxidants 12 00087 g006
Antioxidants 12 00087 g007 550
Figure 7. AUR advanced the morphokinetics of embryos from postovulatory aged oocytes. (a) Comparison of the morphokinetics of embryos derived from oocytes of the Young, POA, POA+AUR 1 μM and POA+AUR 10 μM groups. (b) Representative images of embryos from aged oocytes that had not reached the blastocyst stage. (c–q) t2, t3, t4, t5, t6, t7, and t8: time in hours post insemination (HPI) required for embryos to reach the 2-, 3-, 4-, 5-, 6-, 7-, and 8-cell stage, respectively; tErB: time to start formation of blastocoel cavity; tBL: half or more of blastocoel cavity had formed; CC: length of the cell cycle; S: synchronicity or round of cleavage division. Dots of boxplot show individual values of each observation. Data are presented as the means ± SEMs of at least three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 7. AUR advanced the morphokinetics of embryos from postovulatory aged oocytes. (a) Comparison of the morphokinetics of embryos derived from oocytes of the Young, POA, POA+AUR 1 μM and POA+AUR 10 μM groups. (b) Representative images of embryos from aged oocytes that had not reached the blastocyst stage. (c–q) t2, t3, t4, t5, t6, t7, and t8: time in hours post insemination (HPI) required for embryos to reach the 2-, 3-, 4-, 5-, 6-, 7-, and 8-cell stage, respectively; tErB: time to start formation of blastocoel cavity; tBL: half or more of blastocoel cavity had formed; CC: length of the cell cycle; S: synchronicity or round of cleavage division. Dots of boxplot show individual values of each observation. Data are presented as the means ± SEMs of at least three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001.
Antioxidants 12 00087 g007
Antioxidants 12 00087 g008 550
Figure 8. Auraptene can effectively delay postovulatory oocyte aging in vitro by alleviating oxidative stress. Briefly, we found that AUR inhibited not only spindle defects but also mitochondrial dysfunctions. In addition, the AUR treatment showed exhibit high GSH level and increase expression of antioxidant enzymes (Nrf2, Gclm, Gclc, Gpx1 and Sod1) while decreasing the ROS level. Moreover, AUR can improve fertilization and preimplantation embryo development. Thus, we conclude that AUR may be able to provide as a potent antioxidant in clinical.
Figure 8. Auraptene can effectively delay postovulatory oocyte aging in vitro by alleviating oxidative stress. Briefly, we found that AUR inhibited not only spindle defects but also mitochondrial dysfunctions. In addition, the AUR treatment showed exhibit high GSH level and increase expression of antioxidant enzymes (Nrf2, Gclm, Gclc, Gpx1 and Sod1) while decreasing the ROS level. Moreover, AUR can improve fertilization and preimplantation embryo development. Thus, we conclude that AUR may be able to provide as a potent antioxidant in clinical.
Antioxidants 12 00087 g008
Table
Table 1. Primers used for real-time RT–PCR.
Table 1. Primers used for real-time RT–PCR.
GenesAccession No.ForwardReverseProduct Size (bp)
Nrf2NM_010902.4TGGAGAACATTGTCGAGCTGTGCTTTTGGGAACAAGGAAC237
Keap1NM_001110307.1GGCAGGACCAGTTGAACAGTATCACTGTCCGGGTCATAGC188
Sod1NM_011434.2TGCTTTTGGGAACAAGGAACCACCTTTGCCCAAGTCATCT216
CatNM_009804.2CCTGACATGGTCTGGGACTTCAAGTTTTTGATGCCCTGGT201
Nqo1NM_008706.5CAGATCCTGGAAGGATGGAATCTGGTTGTCAGCTGGAATG202
Gpx1NM_008160.6GTCCACCGTGTATGCCTTCTTCTGCAGATCGTTCATCTCG152
GclcNM_010295.2CAATGGGAAGGAAGGGGTATTCAGGATGGTTTGCAATGAA186
GclmNM_008129.4TGGAGCAGCTGTATCAGTGGAGAGCAGTTCTTTCGGGTCA150
GapdhNM_001289726.1ACCACAGTCCATGCCATCACTCCACCACCCTGTTGCTGTA171
H1fooNM_001346702.1TCCACCACAAGTACCCGACAGGCACAGGCTTTCTTTCTCT173
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kim, Y.-H.; Lee, S.-Y.; Kim, E.-Y.; Kim, K.-H.; Koong, M.-K.; Lee, K.-A. The Antioxidant Auraptene Improves Aged Oocyte Quality and Embryo Development in Mice. Antioxidants 2023, 12, 87. https://doi.org/10.3390/antiox12010087

AMA Style

Kim Y-H, Lee S-Y, Kim E-Y, Kim K-H, Koong M-K, Lee K-A. The Antioxidant Auraptene Improves Aged Oocyte Quality and Embryo Development in Mice. Antioxidants. 2023; 12(1):87. https://doi.org/10.3390/antiox12010087

Chicago/Turabian Style

Kim, Yun-Hee, Su-Yeon Lee, Eun-Young Kim, Kyeoung-Hwa Kim, Mi-Kyoung Koong, and Kyung-Ah Lee. 2023. "The Antioxidant Auraptene Improves Aged Oocyte Quality and Embryo Development in Mice" Antioxidants 12, no. 1: 87. https://doi.org/10.3390/antiox12010087

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop